Disc Medicine Reaches Analyst Target Price
March 04, 2024 at 06:56 AM EST
In recent trading, shares of Disc Medicine Inc (IRON) have crossed above the average analyst 12-month target price of $74.56, changing hands for $75.32/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..